98%
921
2 minutes
20
Background: Presbyopia is defined as the age-related deterioration in the ability to focus on close objects, causing difficulty with near vision tasks. The study aim was to understand the lived experience of phakic presbyopia and identify all relevant visual function symptoms and associated functional impacts.
Methods: Fifty individuals with clinician-confirmed phakic presbyopia (US n = 30, France n = 10, Germany n = 10) and seven healthcare professionals (HCPs) participated in in-depth, face-to-face, qualitative concept elicitation interviews. Verbatim transcripts were analyzed using thematic analysis methods.
Results: Visual function symptoms reported by participants with phakic presbyopia were categorized as: primary near vision functioning symptoms (impaired near visual acuity, n = 50/50, 100%; difficulty with near vision in dim light, n = 42/50, 84%; difficulty focusing at close distances, n = 30/50, 60%; difficulty seeing things when glare is present, n = 30/50, 60%) and secondary symptoms (eye strain, n = 37/50, 74%; dry eyes, n = 35/50, 70%; headaches, n = 30/50, 60%). Proximal impacts on functional vision included difficulty reading in near vision (n = 49/50, 98%, including printed text and handwriting), seeing objects in near vision n = 48/50, 96%, and performing activities of daily living that require near vision (n = 49/50, 98%, including using a smartphone or computer). Distal impacts on functional vision included emotional, work, financial and social impacts. HCP interviews supported participant findings.
Conclusion: Findings provide a comprehensive understanding of the lived experience of phakic presbyopia which informed the development of a presbyopia conceptual model and patient-reported outcome assessments of vision correction independence and near vision functioning. The sample did not include those whose vision cannot be adequately corrected with lenses or surgery.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566618 | PMC |
http://dx.doi.org/10.1186/s41687-021-00383-1 | DOI Listing |
J Ophthalmol
July 2025
Department of Ophthalmology, Havlickuv Brod Hospital, Havlickuv Brod, Czech Republic.
To report the visual outcomes following bilateral implantation of a new trifocal intraocular lens (IOL) in patients with age-related cataracts. This prospective, noncomparative, multicenter study assessed 126 patients undergoing cataract extraction followed by AT ELANA 841P IOL implantation. At 4-6 months postoperatively, refractive error and predictability, monocular uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected intermediate visual acuity (UIVA), distance-corrected intermediate visual acuity (DCIVA), uncorrected near visual acuity (UNVA), distance-corrected near visual acuity (DCNVA), and binocular contrast sensitivity were measured.
View Article and Find Full Text PDFClin Optom (Auckl)
June 2025
Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Objective: The purpose of this study was to compare the near add power among glaucoma patients using prostaglandin F (FP) receptor agonists and fixed combination therapies and controls.
Methods: Participants were aged from 40 to 69 years and phakic with visual acuity of 20/25 or better, and included 2200 controls, 784 patients using FP receptor agonist for primary open-angle glaucoma (FP), and 412 patients using fixed combination (Combi). Each group was further divided into three groups based on age: those aged 40 to 49 years (40s), those aged 50 to 59 years (50s), and those aged 60 to 69 years (60s), and the near add power at 30 cm and various ophthalmic factors were compared.
J Cataract Refract Surg
June 2025
IMO Instituto de Microcirugía Ocular, Barcelona, Spain.
Purpose: To evaluate the six-month effectiveness and safety of a novel foldable multifocal iris-fixated phakic IOL (pIOL) for presbyopia correction.
Setting: Multicenter study at 7 sites.
Design: Nonrandomized prospective clinical trial.
Transl Vis Sci Technol
May 2025
Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Purpose: The aim of this study was to compare the near add power of glaucoma patients and controls between the ages of 40 and 79 years.
Methods: This was a cross-sectional study of 2724 bilateral phakic participants aged between 40 and 79 years, which included 1615 controls and 1109 patients with primary open-angle glaucoma who were using prostaglandin F (FP) receptor agonists. Participants were classified into eight age groups: 40-44, 45-49, 50-54, 55-59, 60-64, 65-69, 70-74, and 75-79 years of age.
J Cataract Refract Surg
May 2025
Dept. Ophthalmology, University Hospital Leuven, Belgium ( , , ).
Topic: To assess the visual outcome and safety of the (diffractive) Implantable Phakic Contact Lens (IPCL). Comparative data to the Implantable Collamer Lens (ICL) will be provided whenever possible.
Clinical Relevance: The IPCL is a more recent posterior-chamber phakic intra-ocular lens (pIOL) which is less expensive, offering a more cost-efficient alternative to the well-known ICL.